Eric M. Sanford - Concepedia

Concepedia

Author

Eric M. Sanford

Foundation Medicine (United States)ORCID

Also Known As

E M Sanford, E. Sanford, E.M. Sanford, Eric M Sanford, Eric M. Sanford, Eric Michael Sanford, Eric Sanford

58

Publications

4.7K

Citations

18

H-Index

53

Concepts

All Affiliations

Foundation Medicine (United States)Albany Medical Center Hospital Memorial Sloan Kettering Cancer Center University of California, Irvine University of Pennsylvania

EM

About

Eric M. Sanford is an author at Foundation Medicine (United States) specializing in medicine, pathology, and molecular diagnostics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	2.9K
2	Engineering	3	3	2.2K
3	Health Sciences	2	2	142
4	Natural Sciences	2	2	131
5	Biostatistics	2	2	27

Eric M. Sanford

×

20

Publications

4.7K

Citations

17

H-Index

	Year	Citations
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing Garrett M. Frampton, Alex Fichtenholtz, Geoff Otto, Nature Biotechnology Dna SequencingClinical CancerEngineeringTumor HeterogeneityMedicine	2013	2.1K
Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors Garrett M. Frampton, Siraj M. Ali, Mark R. Rosenzweig, Cancer Discovery	2015	782
A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal James Sun, Yuting He, Eric M. Sanford, PLoS Computational Biology	2018	274
A Novel Next-Generation Sequencing Approach to Detecting Microsatellite Instability and Pan-Tumor Characterization of 1000 Microsatellite Instability–High Cases in 67,000 Patient Samples Sally E. Trabucco, Kyle Gowen, Sophia L. Maund, Journal of Molecular Diagnostics	2019	212
Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease Rona Yaeger, Manish A. Shah, Vincent A. Miller, Gastroenterology Genomic Alterations ObservedSporadic Colorectal CancersMedicineImmunologyGastroenterology	2016	193
Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome Olivia Padovan‐Merhar, Pichai Raman, Irina Ostrovnaya, PLoS Genetics Neuro-oncologySomatic VariantHealth SciencesGliomaTumor Heterogeneity	2016	130
Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive <i>ALK</i>-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization Siraj M. Ali, Thomas A. Hensing, Alexa B. Schrock, The Oncologist	2016	114
Identification and characterization of <i>RET</i> fusions in advanced colorectal cancer Anne-France Le Rolle, Samuel J. Klempner, Christopher R. Garrett, Oncotarget Surgical OncologyPathologyAdvanced Colorectal CancerCancer BiologyTumor Biology	2015	109
Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes Jon Chung, Eric M. Sanford, Adrienne Johnson, Annals of Oncology EngineeringTumor HeterogeneityComprehensive Genomic ProfilingMedicinePathology	2016	99
HER2-Overexpressing Breast Cancers Amplify FGFR Signaling upon Acquisition of Resistance to Dual Therapeutic Blockade of HER2 Ariella B. Hanker, Joan T. Garrett, Mónica V. Estrada, Clinical Cancer Research	2017	97

Page 1